Lipitas 20 Tablet contains Rosuvastatin 20 mg, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia to reduce elevated levels of low-density lipoprotein cholesterol (LDL-C), total cholesterol, and triglycerides, while modestly increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to decreased hepatic cholesterol production and increased clearance of LDL particles from the bloodstream. Lipitas 20 is prescribed to patients at high risk of cardiovascular events, including those with a history of coronary artery disease, stroke, or peripheral arterial disease, to prevent atherosclerosis progression. The medication is typically administered once daily, with or without food, and dosage adjustments may be necessary based on therapeutic response and patient tolerance. Common adverse effects include headache, myalgia, and gastrointestinal disturbances, while rare but serious side effects such as myopathy and hepatotoxicity require monitoring of liver enzymes and creatine kinase levels during therapy. Lipitas 20 should be used cautiously in patients with hepatic impairment or renal dysfunction, and contraindicated during pregnancy and lactation. Regular lipid profile assessments are recommended to evaluate treatment efficacy.